Nearly half of the comments submitted to the US Food and Drug Administration on the agency’s proposed rule to establish an over-the-counter (OTC) hearing aid category were part of scheme by some in the industry to undermine and weaken the proposal, Sens. Elizabeth Warren, D-MA, and Chuck Grassley, R-IA, allege.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?